1 / 9

TAVR for Younger and Bicuspid Valve Patients

Chronic Total Occlusion (CTO) remains one of the mostcomplex challenges in interventional cardiology, but rapid advancements in techniques and technology have dramatically changed treatment outcomes. Many individuals researching the best cardiology doctor in Bhubaneswar often come across discussions on modern CTO PCI because it represents one of the highest-skill procedures in coronary intervention.

Gyana2
Download Presentation

TAVR for Younger and Bicuspid Valve Patients

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. TAVR for Younger and Bicuspid Valve Patients Evolving Evidence • Patient Selection • Clinical Outcomes

  2. INTRODUCTION Chronic Total Occlusion (CTO) remains one of the mostcomplex challenges in interventional cardiology, but rapid advancements in techniques and technology have dramatically changed treatment outcomes. Many individuals researching the best cardiology doctor in Bhubaneswar often come across discussions on modern CTO PCI because it represents one of the highest-skill procedures in coronary intervention. Dr. Gyana Ranjan Nayak, an interventional cardiologist with experience in complex PCI, frequently manages CTO cases that would have been considered extremely difficult a decade ago. Understanding these advancements helps patients appreciate how far cardiology has progressed.

  3. Overview • - Transcatheter Aortic Valve Replacement (TAVR) is expanding beyond elderly high‑risk groups. • - Increasing interest in younger (<65) and bicuspid aortic valve (BAV) patients. • - Requires careful consideration of durability, anatomy, and long-term follow-up.

  4. Why Younger Patients Are Being Considered • - Less invasive option vs. surgical aortic valve replacement (SAVR). • - Faster recovery and shorter hospital stay. • - Emerging data shows comparable early outcomes to older cohorts. • - Quality-of-life benefits are significant.

  5. Challenges in Younger Patients • - Valve durability concerns over decades-long lifespan. • - Higher lifetime risk of re-interventions. • - Coronary access after TAVR can be difficult for future procedures. • - Need for long-term data to validate safety.

  6. Bicuspid Valve Challenges • - Asymmetric calcification makes expansion harder. • - Higher risk of paravalvular leak. • - Larger, elliptical annulus vs. tricuspid morphology. • - Requires careful CT-based planning.

  7. Evidence & Outcomes • - Recent registries show improved device success in bicuspid valves. • - New-generation valves reduce leak risk significantly. • - Short-term outcomes approaching tricuspid TAVR results. • - Ongoing trials assessing long-term durability.

  8. Patient Selection • - Younger patients should undergo heart team evaluation. • - Favorable anatomy: minimal raphe calcification, suitable annulus. • - Consider surgical option when long-term durability is a priority. • - TAVR suitable for high-risk or anatomy-appropriate cases.

  9. Future Directions • - New valve designs tailored for bicuspid anatomy. • - Improved commissural alignment for future coronary access. • - Long-term follow-up data expected to shift guidelines. • - Personalized imaging and AI-driven sizing improvements.

More Related